BRAINSWAY LTD/S (NASDAQ:BWAY) shares were up 17% during trading on Monday . The stock traded as high as $11.24 and last traded at $10.80, approximately 187,875 shares were traded during trading. An increase of 1,565% from the average daily volume of 11,283 shares. The stock had previously closed at $9.23.
BWAY has been the subject of several analyst reports. Raymond James lowered their price objective on BRAINSWAY LTD/S from $14.00 to $13.00 and set an “outperform” rating for the company in a research report on Tuesday, November 26th. Zacks Investment Research cut BRAINSWAY LTD/S from a “hold” rating to a “sell” rating in a research report on Friday, November 22nd. One analyst has rated the stock with a sell rating and five have assigned a buy rating to the company. The stock has a consensus rating of “Buy” and a consensus price target of $15.60.
The company has a 50-day moving average price of $8.99 and a 200-day moving average price of $9.73.
About BRAINSWAY LTD/S (NASDAQ:BWAY)
Brainsway Ltd. engages in the development and provision of technology solutions for non-invasive treatment of brain disorders in Israel and internationally. It offers deep transcranial magnetic stimulation systems for treating various conditions, including autism, Alzheimer's disease, bipolar disorders, chronic pains, depressive disorders, Parkinson's diseases, schizophrenia, smoking cessation, post-traumatic stress disorders, multiple sclerosis, obsessive compulsive disorders, and stroke rehabilitation.
Further Reading: Stocks Increasing Dividends
Receive News & Ratings for BRAINSWAY LTD/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BRAINSWAY LTD/S and related companies with MarketBeat.com's FREE daily email newsletter.